The two-faced T cell epitopeLeonard Moise, Anne S. De Groot, Andrés H. Gutiérrez et al.|Human Vaccines & Immunotherapeutics|2013Cited by 107
Modulation of CD8+ T cell responses to AAV vectors with IgG-derived MHC class II epitopesDaniel J. Hui, Federico Mingozzi, Etiena Basner‐Tschakarjan et al.|Molecular Therapy|2013Cited by 45
Tregitope Peptides: The Active Pharmaceutical Ingredient of IVIG?Anne S. De Groot, William J. Martin, Leslie P. Cousens et al.|Clinical and Developmental Immunology|2013Cited by 23
Teaching toleranceLeslie P. Cousens, Anne S. De Groot, Federico Mingozzi et al.|Human Vaccines & Immunotherapeutics|2012Cited by 18
Preclinical design of less immunogenic biologics: Tregitopes and Tolerance (144.28)Janet E. Buhlmann, Anne S. De Groot, Nader Najafian et al.|The Journal of Immunology|2010Cited by 1